References
- Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375–382
- Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y, et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23: 87–89
- Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15–20
- Mitra-Kaushik S, Harding J, Hess J, Schreiber R, Ratner L. Enhanced tumorigenesis in HTLV-1 Tax transgenic mice deficient in interferon-gamma. Blood 2004; 104: 3305–3311
- Tamura K, Makino S, Araki Y, Imamura T, Seita M. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 1987; 59: 1059–1062
- Ishihara K. Therapeutic effect of OH-6000, a natural interferon-γ, in patients with adult T-cell leukemia: a survey of prognosis of late phase II clinical trial [in Japanese]. Skin Cancer 2000; 15: 184–190
- Fujiwara H, Arima N, Akasaki Y, Ohtsubo H, Ozaki A, Kukita T, et al. Interferon-α therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma. Acta Haematol 2002; 107: 213–219
- Gill P S, Harrington W, Jr, Kaplan M H, Ribeiro R C, Bennett J M, Liebman H A, et al. Treatment of adult T-cellleukemia-lymphoma with a combination of interferon alfa and zidovudine. New Engl J Med 1995; 332: 1744–1748